Molecular Basis of Myocardin Function in the Heart
心脏心肌素功能的分子基础
基本信息
- 批准号:7565445
- 负责人:
- 金额:$ 42.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Transcriptional co-activators expand information encoded within the genome required for adaptation to environmental perturbation and stress. Myocardin is a remarkably potent transcriptional expressed exclusively in the heart and smooth muscle cells (SMCs). We have used transgenic and gene targeting strategies in mice to elucidate the molecular mechanisms that regulate heart and vascular development. Preliminary studies reveal that: i) myocardin is expressed in a precise developmentally regulated pattern in cardiomyocytes and SMCs, ii) forced expression of myocardin in embryonic stem cells activates cardiac-restricted genes associated with the hypertrophic gene program, iii) myocardin and MRTF-A activate overlapping, but distinct, sets of genes and most importantly iv) mice harboring a cardiac-specific conditional ablation of the myocardin gene exhibit hypertrophic cardiomyopathy. Together these studies suggest the central hypothesis that will be examined in the proposed studies: myocardin functions as a central regulator of cardiomyocyte growth and adaptation to stress via both feed-forward mechanisms, including activation of genes associated with the fetal /hypertrophic gene program, and feedback mechanisms regulating cell proliferation. The overall goal of this proposal is to elucidate the role of myocardin in the heart with particular focus on defining its function in cardiac myocyte differentiation and adaptation of the heart. The specific aims are to characterize: 1) the SRF- and MEF2-dependent transcriptional and morphogenetic programs regulated by myocardin in the heart, 2) mechanisms that distinguish activity and specificity of myocardin, MRTF-A and MRTF-B in the heart, and 3) molecular mechanisms modulating myocardin-dependent transcriptional activation in the adult heart and response to hypertrophic stimuli. The experimental strategy deployed emphasizes the translation and validation of molecular and cellular data in genetically engineered mice. At a basic level these studies will provide new insights into the transcriptional programs regulating cardiac myocyte differentiation and morphogenetic development of the heart. These studies also provide insights into the molecular mechanisms regulating adaptation of the heart to stress and the pathogenesis of cardiomyopathy. PUBLIC HEALTH RELEVANCE: This application will investigate how the transcriptional coactivator, Myocardin, regulates the differentiated state of the heart and the capacity of the heart to respond to hemodynamic stress. We have generated genetically altered mice with cardiac-restricted ablation of the Myocardin gene. Analysis of these mice will permit us to determine if myocardin controls the early differentiation of cardiac myocytes, as well as their role in re-programming gene expression in the adult heart when it is subjected to stress. These studies will provide new understanding into cardiac development as well as the underlying causes of heart failure and cardiomyopathy.
描述(由申请人提供):转录共激活器扩展了适应环境扰动和压力所需的基因组中编码的信息。心肌素是一种非常有效的转录,仅在心脏和平滑肌细胞(SMC)中表达。我们已经在小鼠中使用了转基因和基因靶向策略来阐明调节心脏和血管发育的分子机制。初步研究表明:i)心肌在心肌细胞和SMC中以精确的发育调节模式表达,ii)在胚胎干细胞中强迫肌动蛋白在胚胎干细胞中激活了与肥大基因程序相关的心脏限制基因,III和MRTF-A活化的基因,但属于MIRTF-A的基因,但属于MIRTF-A的属性,最重要的是属于属性的概念,最重要的是概念的概念,最重要的是属于基因的基因。心肌基因的心脏特异性有条件消融表现出肥大性心肌病。这些研究共同提出了将在拟议的研究中进行研究的中心假设:心肌素作为心肌细胞生长的中心调节剂,并通过两种喂养前馈机制适应压力,包括激活与胎儿 /肥大基因程序相关的基因,以及调节细胞扩散的反馈机制。该提案的总体目标是阐明心肌在心脏中的作用,尤其着重于定义其在心肌细胞分化和心脏适应中的功能。具体目的是表征:1)肌动蛋白在心脏中调节的SRF-和MEF2依赖性转录和形态发生程序,2)在心脏中区分肌心脏机制和3)分子机制在成人心脏依赖性的触发性转移中,从而区分心脏中肌心脏机制的运动和特异性。部署的实验策略强调了基因工程小鼠中分子和细胞数据的翻译和验证。在基本层面上,这些研究将为调节心脏心肌分化和心脏形态发生发展的转录程序提供新的见解。这些研究还提供了对调节心脏适应压力和心肌病发病机制的分子机制的见解。公共卫生相关性:该应用将调查转录共激活剂Mycardin如何调节心脏的差异化状态和心脏能够应对血液动力学压力的能力。我们已经产生了遗传改变的小鼠,并用心脏限制的心肌蛋白基因消融。对这些小鼠的分析将使我们能够确定心肌素是否控制心肌细胞的早期分化,以及它们在受到压力时在成年心脏中重新编程基因表达中的作用。这些研究将为心脏发展以及心力衰竭和心肌病的根本原因提供新的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Michael S Parmacek的其他基金
Myocardin Related Transcription Factor Function in the Vasculature
脉管系统中心肌素相关转录因子的功能
- 批准号:79064437906443
- 财政年份:2010
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Myocardin Related Transcription Factor Function in the Vasculature
脉管系统中心肌素相关转录因子的功能
- 批准号:80639518063951
- 财政年份:2010
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Myocardin Related Transcription Factor Function in the Vasculature
脉管系统中心肌素相关转录因子的功能
- 批准号:84443158444315
- 财政年份:2010
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Myocardin Related Transcription Factor Function in the Vasculature
脉管系统中心肌素相关转录因子的功能
- 批准号:82435688243568
- 财政年份:2010
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Molecular Basis of Myocardin Function in the Heart
心脏心肌素功能的分子基础
- 批准号:78513357851335
- 财政年份:2009
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
MYOCARDIN AND VASCULAR SMOOTH MUSCLE
心肌素和血管平滑肌
- 批准号:69296646929664
- 财政年份:2004
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
REG OF SM22 ALPHA TRANSCRIPTION IN SMOOTH MUSCLE CELLS
平滑肌细胞中 SM22 α 转录的调节
- 批准号:61837726183772
- 财政年份:1997
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
REG OF SM22 ALPHA TRANSCRIPTION IN SMOOTH MUSCLE CELLS
平滑肌细胞中 SM22 α 转录的调节
- 批准号:26855002685500
- 财政年份:1997
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Reg of SM22 Alpha Transcription in Smooth Muscle Cells
平滑肌细胞中 SM22 Alpha 转录的调节
- 批准号:63322796332279
- 财政年份:1997
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
REG OF SM22 ALPHA TRANSCRIPTION IN SMOOTH MUSCLE CELLS
平滑肌细胞中 SM22 α 转录的调节
- 批准号:29012632901263
- 财政年份:1997
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
相似国自然基金
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
高效合成人参皂苷CK的酵母细胞工厂的研究
- 批准号:21672228
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
- 批准号:81570122
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
基于IVIM-DWI的成人肾脏肿瘤影像生物学标记及其病理学基础研究
- 批准号:81471641
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
成人上呼吸道感染病人中人冠状病毒病原谱及生物学特性研究
- 批准号:81100062
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:1074877610748776
- 财政年份:2024
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:1065108210651082
- 财政年份:2023
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
- 批准号:1059436610594366
- 财政年份:2023
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Sensory Mechanisms of Cadmium-Induced Behavioral Disorders Across Generations
镉引起的几代人行为障碍的感觉机制
- 批准号:1074755910747559
- 财政年份:2023
- 资助金额:$ 42.82万$ 42.82万
- 项目类别:
Formation of a functional tendon enthesis during development and healing
在发育和愈合过程中形成功能性肌腱附着点
- 批准号:1058739910587399
- 财政年份:2023
- 资助金额:$ 42.82万$ 42.82万
- 项目类别: